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Background:  Revision  total  hip  arthroplasty  (reTHA)  for peri-prosthetic  fracture  (PPF)  is  increasingly
performed  but still  ranks  fourth  among  reasons  for reTHA  in  registries.  In France,  no  speciﬁc  registry
is  available  and  the  frequency  of PPF among  reasons  for THA  revision  is therefore  unknown.  Here,  our
objectives  were  to determine  the relative  frequency  of PPF  as a reason  for  reTHA, to  identify  patient-
related  and primary-THA-related  factors  associated  with  reTHA  for  PPF,  to describe  reTHA  modalities  for
PPF,  and to determine  the  morbidity  and  mortality  associated  with  reTHA  for  PPF.
Hypothesis:  PPF  is the  second  most  common  reason  for reTHA,  after  loosening.
Methods:  Consecutive  reTHA  procedures  performed  in  30 French  centres  over  a 2-year  period  were
collected  prospectively.  Repeat  revisions  and  revisions  of hemi-arthroplasties  were  excluded.  The  epi-
demiological,  clinical,  and  surgical  data  needed  to answer  the  questions  of  the  study  were  collected.
Results:  PPF was  the second  leading  reason  for reTHA  (249/2107,  11.8%).  Vancouver  type  B2  fractures  were
the most  common  (n = 127  [51.5%]).  Compared  to  patients  who  underwent  reTHA  for reasons  other  than
PPF,  those  with  reTHA  for PPF  were  older  at primary  THA  (67.9  years versus  57.7 years)  and  more  often
had  intra-operative  complications  (16.9%  versus  11.6%);  furthermore,  the primary  THA  was  more  often
cementless  (62.7%  versus  42.7%)  with  a dual-mobility  cup (20.6%  versus  11.1%).  At reTHA,  the  patients
with  PPF  were  older  (77.6  years  versus  69.2 years),  had  worst  medical  condition  (mean ASA score,  2.4
versus  2.1)  and  less  physically  active  (mean  Devane  score,  2.1 versus  2.4).  The  patients  with  reTHA  for  PPF
had  a shorter  time  to  revision  (9.8  years  versus  11.4 years),  a  longer  operative  time  (144 minutes  versus
128  minutes),  and  more  frequent  use  of  the  posterior  approach  (77%  versus  67%) with  a  cementless  dual-
mobility  cup  (78%  versus  60%)  and  a cementless  revision  femoral  stem  (72%  versus  50%).  Morbidity  and
mortality  rates  were  high  (5.9%  operative  complication  rate  and  12%  of  surgical  complications  with  4.8%
mortality  within  the ﬁrst  3 months)  however,  these  results  were  similar  to  those  in the  rest  of the  cohort.
Discussion  and  conclusion:  PPF  is the  second  most  common  reason  for reTHA,  a  result  that  is  at variance
with  data in  national  registries.
Level  of evidence:  Level  IV, prospective  observational  cohort  study.. IntroductionTotal hip arthroplasty (THA) is the ‘operation of the century’
ccording to Learmonth et al. [1] in 2007. Despite improvements in
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the techniques, approaches, and prosthetic materials and designs,
THA survival remains limited and the frequency of revision THA
(reTHA) is increasing steadily [2]. In national registries, the main
reasons for the ﬁrst reTHA are as follows, in order of decreasing
frequency: aseptic loosening, instability, infection, peri-prosthetic
fracture (PPF), and pain [3–8]. To compensate for the absence of
a national registry in France, the Société franc¸ aise de chirurgie
orthopédique et de traumatologie (SoFCOT) launched a prospective
6 tology: Surgery & Research 100 (2014) 657–662
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tudy in 2009 to evaluate the epidemiology of ﬁrst reTHA proce-
ures, with the goal of elucidating the reasons for primary THA
ailure [9]. The data thus obtained have been used to assess reTHAs
ue to dislocation and infection [10,11], and the current study
ocused speciﬁcally on reTHA due to PPF.
The occurrence of PPF is increasing steadily, as a result of
ncreases in life expectancy and number of THA procedures [10]. In
rance in 2006, the frequency of PPF was about 0.1 to 2% after THA
nd 0.3 to 2.5% after total knee arthroplasty [12]. Inter-prosthetic
ractures of the femoral shaft are also uncommon (1.25%) [13].
The primary objective of this study was to determine the fre-
uency of PPF among the other reasons for reTHA. We  hypothesised
hat PPF was the second leading reason for the ﬁrst reTHA after
oosening. Our secondary objectives were to look for patient-
elated factors associated with reTHA for PPF, types of primary THA
ssociated with reTHA for PPF, speciﬁc reTHA modalities in this
ndication, and the morbidity and mortality rates associated with
eTHA for PPF.
. Patients and method
.1. Patients
We  conducted a prospective multicentre cohort study over
he 2-year period from January 2010 to December 2011. All the
embers of the French Society for Hip and Knee Surgery (Société
ranc¸aise de chirurgie de la hanche et du genou) who performed
t least 30 reTHA procedures per year were invited to participate.
e conﬁned our study to the ﬁrst reTHA after the primary THA;
hus, repeat reTHAs were excluded. We  also excluded reTHA after
emi-arthroplasty. We  deﬁned reTHA as a change of at least one
omponent of the primary THA.
We identiﬁed 2153 reTHA procedures performed over the
-year study period in 30 surgical departments (24 in public uni-
ersity and general hospitals and 6 in private institutions).
.2. Assessment methods
We  recorded the diagnosis leading to primary THA, age at pri-
ary THA, sex, and previous surgical procedures on the native
ip. The following data at the time of reTHA were collected: age,
pproach, mode of prosthetic ﬁxation, implant types, body mass
ndex (BMI), American Society of Anesthesiologists (ASA) score
14], Merle d’Aubigné-Postel (MAP) score [15], Charnleycategory
16], Oxford-12 Hip Score in its validated French version [17]
nd Devane activity score [18]. We  obtained details on all intra-
perative and postoperative surgical complications and all medical
omplications seen within the ﬁrst 3 months. Femoral PPFs were
lassiﬁed using the Vancouver system [19]. We  deﬁned senior sur-
eons as surgeons having completed their clinical fellowship. For
riction couple analysis, steel, cobalt-chromium, and titanium were
ooled into a single ‘metal’ category; standard polyethylene (PE)
nd highly reticulated PE into a single ‘PE’ category; and alumina
eramics, zirconium ceramics, and DeltaTM ceramics under a single
ceramic’ category.
.3. Statistical methods
The data were collected into an online database (FileMakerTM
ro, San Diego, CA, USA). Of the 2153 cases, we excluded the 46
2%) cases with missing data, which left 2107 cases for the analysis.Descriptive statistics for continuous, ordinal, qualitative, and/or
ominal variables were computed at the biostatistics department
f the Lille University Hospital, Lille, France (SAS version 9.2 and
PSS version 15.0 statistical software). Bivariate comparisons ofFig. 1. Graph showing the distribution of peri-prosthetic fractures according to the
Vancouver classiﬁcation [19].
groups were performed using Student’s t test or analysis of vari-
ance if the sample size was  greater than 30. When the sample size
was less than 30, the Mann-Whitney test or Kruskal-Wallis test
was chosen. Between-group comparisons were achieved using the
Chi2 test or Fisher’s exact test. Logistic regression was  used for the
multivariate analyses.
3. Results
As expected, the leading reason for ﬁrst reTHA was  aseptic loos-
ening, with 891/2107 (42.3%) cases. PPFs were common and came
in second position among reasons for reTHA, with 249/2107 (11.8%)
cases [9].
3.1. Epidemiological features of the population with
peri-prosthetic fractures (PPFs)
PPFs occurred in 249 patients, with a predominance of women
(60.5% versus 39.5% men) (Table 1). Compared to patients with
other reasons for reTHA, those with PPF were older (67.9 years ver-
sus 57.7 years) had worse medical condition (mean ASA score, 2.4
versus 2.1), and were less physically active (mean Devane score, 2.1
versus 2.4). Of the 249 patients with PPFs, only 43 (17.3%) had no
medical comorbidities (Table 1).
3.2. Surgical characteristics of the primary total hip arthroplasty
(THA) in the population with peri-prosthetic fractures (PPFs)
Compared to the group with other reasons for reTHA (Table 2),
the group with PPF had higher proportions of patients with
osteoarthritis as the reason for THA (73% versus 60.5%), THA via
the posterior approach (77.3% versus 65%), no previous surgery
on the hip (93.8% versus 85.6%), cementless ﬁxation (62.7% ver-
sus 42.7%), a dual-mobility cup (20.6% versus 11.1%), and a friction
couple including PE (89.4% versus 80.2%). The PPF group had
higher rates of intra-operative complications (42/249 [16.9%] ver-
sus216/1858 [11.6%]) and of medical complications (35/225 [15.6%]
versus 137/1721 [8%]) (Table 2).
3.3. Characteristics of the revision total hip arthroplasties
(reTHAs) for peri-prosthetic fractures (PPFs)
Mean time from primary THA to reTHA for PPF was 9.8 years,
which was signiﬁcantly shorter than in the rest of the cohort
(11.4 years [Table 1]). Nearly all the PPFs involved the femur
(234/249, 94%), and most of them were type B in the Vancouver
classiﬁcation (204/249, 82%) [19], with a predominance of type B2
(Fig. 1). As with the other reasons for revision, a single component
was changed in most cases of reTHA for PPF. In contrast, reTHA
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Table  1
Comparison of epidemiological data in the group with peri-prosthetic fracture as the reason for revision and in the group with other reasons.
Data Peri-prosthetic fracture Other reasons P value
Gender
Males 98/248 (39.5%) 810/1858 (43.6%) NS
Females 150/248 (60.5%) 1048/1858 (56.4%)
Age  (years) at primary THA 67.9 ± 13 (15–93.9 med  69.5) 57.7 ± 13.6 (13.5–97 med 59.1) < 0.0001
Age  (years) at reTHA 77.6 ± 11.8 (25–103.7 med  80) 69.2 ± 13 (16.5–98 med  71.8) < 0.0001
BMI  at reTHA 25 ± 5.2 (14–62 med  24.2) 26.7 ± 5.3 (14–66 med 26) < 0.0001
ASA  score [14] at reTHA 2.4 ± 0.7 (1–4 med  2) 2.1 ± 0.7 (1–4 med  2) < 0.0001
Devane score [18] at reTHA 2.32 ± 0.98 (1–5 med  2) 2.74 ± 0.9 (1–5 med 3) < 0.0001
MAP  score [15] at reTHA 8.1 ± 6.2 (0–18 med 6) 11.4 ± 3.7 (1–18 med 12) < 0.0001
Oxford-12 hip score [17] at reTHA 37.9 ± 16.3 (12–60 med  38) 37.9 ± 11.9 (12–60 med  39) NS
THA: total hip arthroplasty; reTHA: THA revision; BMI: body mass index; PMA score: Postel-Merle d’Aubigné score; NS: non-signiﬁcant; med: median.
Table 2
Surgical characteristics of primary total hip arthroplasty (THA) in the group with revision for peri-prosthetic fracture (PPF) and in the group with other reasons for revision.
Data Peri-prosthetic fracture Other reasons P value
Reason for primary THA
Osteoarthritis 181/248 (73%) 1125/1452 (60.5%) < 0.0001
Femoral neck fracture 20 (7.7%) 68 (3.7%)
Avascular necrosis of the femoral head 15 (6%) 167 (9%)
Post-traumatic osteoarthritis 12 (4.8%) 92 (5%)
No  hip surgery before primary THA
Yes 221/235 (93.8%) 1543/1797 (85.6%) < 0.001
Surgeon experience
Junior 30/140 (12.5%) 123/1823 (6.7%) < 0.002
Senior  210/240 (87.5%) 1700/1823 (93.3%)
Approach
Posterior 190/246 (77.3%) 1196/1842 (65%) < 0.0001
Lateral  39 (15.9%) 334 (18.1%)
Anterior 10 (4%) 157 (8.5%)
Rottinger 6 (2.5%) 41 (2.2%)
Trochanterotomy 1 (0.4%) 114 (6.2%)
Type of stem
Modular (head) 207/249 (82.9%) 1392/1817 (76.6%) NS
Monobloc 26/249 (10.6%) 276/1817 (15.2%)
Modular (head and neck) 16/249 (6.5%) 149/1817 (8.2%)
Fixation of stem
Cemented 92/246 (37.3%) 1053/1838 (57.3%) < 0.0001
Cementless 154/246 (62.7%) 789/1838 (42.7%)
Type  of cup
Standard 170/243 (70%) 1468/1801 (81.5%) < 0.001
Dual  mobility 50/243 (20.6%) 201/1801 (11.1%)
With  overhang 22/243 (9%) 117/1801 (6.5%)
Retentive 1/243 (0.4%) 15/1801 (0.9%)
Fixation of cup
Cemented 67/244 (28.4%) 722/1836 (39.3%) < 0.001
Cementless 177/244 (71.6%) 1114/1836 (60.7%)
Friction couple
Metal/PE 159/242 (65.7%) 1059/1813 (58.4%) < 0.01
Ceramic/PE 55/242 (22.7%) 396/1813 (21.8%)
Ceramic/Ceramic 22/242 (9.1%) 222/1813 (12.2%)
N
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S: non-signiﬁcant; THA: total hip arthroplasty; PE: polyethylene.
or PPF was more often performed via a posterior approach com-
ared to other reasons for reTHA (77.4% versus 67.3%). In addition,
he PPF group had larger proportions of patients whose revision
mplants were long (88.1% versus 23.4%) and cementless (72.2%
ersus 50.4%) (Table 3). In the PPF group, a dual-mobility cup was
ore often selected for cup changes (78.6% versus 60.3%) and a
ard-on-hard friction couple was less often used (11.5% versus
3%) (Table 3). Table 4 details the adjunctive procedures required
chieﬂy cerclage).136/1813 (7.5%)
The frequency of intra-operative complications (Table 5) was
14/238 (5.9%) in the PPF group, which was not signiﬁcantly differ-
ent from that in the group with other reasons for reTHA (131/1800,
7.3%). The frequency of intra-operative complications was  not sig-
niﬁcantly different between junior and senior surgeons. Within
the ﬁrst 3 months after reTHA, 28/234 (12%) surgical complica-
tions were recorded, with no signiﬁcant difference compared to
the group with reTHA for other reasons (217/1753, 12.4%). Com-
plications in the PPF group were as follows: 11 (4.7%) dislocations,
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Table 3
Surgical characteristics of revision total hip arthroplasty (reTHA) in the group with peri-prosthetic fracture compared to the group with other reasons for revision.
Data Group with peri-prosthetic fracture Group with other reasons for revision P value
Time from THA to reTHA 9.8 ± 8.35 years (8 days–37.1 years med  9.2) 11.4 ± 13 years (1 day–42 years med 11.2) < 0.01
Charnley score [16]
A 150/246 (61%) 984/1836 (53.6%) < 0.02
B  57/246 (23.1%) 630/1836 (34.3%)
C  39/246 (15.8%) 222/1836 (12.1%)
Surgeon experience
Junior 110/249 (44.2%) 335/1853 (18.1%) < 0.0001
Senior  139/249 (55.8%) 1518/1853 (81.9%)
Type  of revision
Partial 138/246 (56.1%) 933/1843 (50.6%) NS
Total  108/246 (43.9%) 910/1843 (49.4%)
Approach
Posterior 188/243 (77.4%) 1222/1815 (67.3%) < 0.001
Lateral  30/243 (12.3%) 263/1815 (14.5%)
Anterior 7/243 (2.9%) 12/1815 (6.7%)
Rottinger 0 21/1815 (1.2%)
Trochanterotomy 18/243 (7.4%) 187/1815 (10.3%)
Type  of femoral stem
Standard 29/233 (12.4%) 611/1031 (59.3%) < 0.0001
Long,  locked 94/233 (40.4%) 155/1031 (15%)
Long,  unlocked 110/233 (47.2%) 265/2013 (25.7%)
Modularity of femoral stem
Head only 147/232 (63.4%) 812/1060 (76.6%) < 0.0001
Head  + neck 82/232 (35.3%) 210/1060 (19.8%)
Monobloc 3/232 (1.3%) 38/1060 (3.6%)
Fixation of femoral stem
Cemented 65/234 (27.8%) 519/1046 (49.6%) < 0.0001
Cementless 169/234 (72.2%) 527/1046 (50.4%)
Type  of cup
Standard 27/173 (15.6%) 590/1737 (34%) < 0.0001
Dual  mobility 136/173 (78.6%) 1048/1737 (60.3%)
Overhang/Retentive 10/173 (8.8%) 99/1737 (5.7%)
Fixation of cup
Cemented 47/129 (36.4%) 830/1660 (50%) < 0.01
Cementless 82/129 (63.6%) 830/1660 (50%)
Support ring
Yes 47/154 (30.5%) 747/1670 (44.8%) < 0.001
Friction couple
Metal/PE 177/200 (88.5%) 1260/1636 (77%) < 0.001
Ceramic/PE 14/200 (8.5%) 260/1636 (15.9%)
Ceramic/Ceramic 6/200 (3%) 116/1636 (7.1%)
Femoral graft
Allograft 12/29 (41.4%) – –
Autograft 9/29 (31%)
Mixed 3/29 (10.4%)
Substitute 5/29 (17.2%)
Acetabular graft
Allograft 17/33 (51.5%) – –
Autograft 3/33 (9.1%)
Mixed 6/33 (18.2%)
Substitute 7/33 (21.2%)
M
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tOperating time (minutes) 144 ± 65.5 (42–510 med 130) 
ed: median; PE: polyethylene; NS: non-signiﬁcant.
 (3.9%) infections, 4 (1.7%) haematomas, 2 (0.9%) recurrent PPFs,
 (0.4%) femoral stem loosening, and 1 leg length lengthening by
ore than 2 cm.  Finally, 35/225 (15.6%) medical complications
ere recorded including 9 (4%) cardiovascular, 10 (4.5%) pul-
onary, 3 (1.3%) neurological, and 2 (0.9%) renal complications.
ithin the ﬁrst 3 months after reTHA, 12 (4.8%) patients died.. Discussion
This prospective study conﬁrmed our hypothesis that PPF was
he second leading reason for ﬁrst reTHA. This ﬁnding in France127.7 ± 65 (20–490 med 120) < 0.0002
is at variance with data from other countries, where PPF usu-
ally ranks fourth or ﬁfth among reasons for reTHA (Table 6)
[9].
Several limitations of our prospective study must be acknowl-
edged. We  did not include all the centres in France. Some data
were missing, despite the prospective study design. We  do not
have any information on the source population within which the
patients with reTHA came from and, more speciﬁcally, we  do not
know which ﬁxation methods were used for the total number
of primary THAs. This point may  explain the predominance of
cementless THAs in the group with reTHA for PPF. The statistical
M. Ehlinger et al. / Orthopaedics & Traumatology
Table  4
Details on adjunctive procedures.
Procedure n/209 %
Cerclage only 155 74.1
Femorotomy 32 15.3
Plate + cerclage 8 3.8
Cerclage + trochanteric plate 6 2.9
Trochanteric hook only 4 1.9
Plate only 2 1
Acetabular plate 2 1
Table 5
Details on intra-operative complications during revision total hip arthroplasty
(reTHA) for peri-prosthetic fracture (PPF).
Intra-operative complication n/238 %
Femoral fracture 6 2.5
Acetabular fracture/breached acetabular fossa 3 1.3
Trajectory error 2 0.8
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close to those reported in elderly patients with femoral neck or
T
CMassive haematoma 2 0.8
Femoral vein injury 1 0.4
nalyses are open to discussion, since they compared several
ifferent reasons for revision but did not enable us to identify
eﬁnite risk factors for revision. This fact emphasises the need
or establishing a national registry. In contrast, our conclusions
egarding the description of the PPF population are valid, since
he data were collected prospectively and the sample size was
arge.
The typical patient with reTHA for PPF in our study was  a woman
ounger than 80 years who was in fair general health, was self-
ufﬁcient but with a low level of physical activity, and had fair hip
unction after primary THA. Data on PPFs at the hip and knee were
eported at the 2005 SoFCOT symposium [10]. Compared to this
arly study, despite the ageing of the population, the typical patient
roﬁle associated with PPF has shown little change, apart from a
light decline in general health.
The epidemiological snapshot provided by our study delineates
he typical primary THA procedure at greater risk for PPF. Factors
ssociated with reTHA for PPF were a cementless prosthesis with
 metal/polyethylene couple implanted via the posterior approach
or osteoarthritis, more often with a dual-mobility cup than in the
roup without PPF. The greater proportion of patients with dual-
obility cups in the PPF group may  be ascribable to load transfer on
o the proximal femur, given the greater stability of the prosthesis,
hich is no longer the weakest component. Our data differ from
hose in the Norwegian registry [20], in which THA for femoral neck
racture was a risk factor for PPF (relative risk, 5; P = 0.002), whereas
steoarthritis was the most common reason for reTHA for PPF in our
tudy.
The femoral fracture type in the Vancouver classiﬁcation [19]
as consistent with the study reported at the 2005SoFCOT sympo-
ium [10], in which type B predominated (61% in the retrospective
nd 55% in the prospective dataset). More speciﬁcally, among type B
ractures, the proportion of type B1 fractures was  increased in
he 2005 study (6% retrospectively and 17.6% prospectively), in
ccordance with our ﬁndings. The proportion of type B2 fractures
able 6
omparison of percentages of patients requiring revision total hip arthroplasty (reTHA) f
Registry or study Year reTHA for 
Australian registry [3] 2011 14.7 
Swedish registry [5] 1979–2000 5.1 
National joint registry for England and Wales [6] 2011 8 
New  Zealand registry [7] 2010 9.5 
Bozic  et al. [8] 2005–2006 6.2 
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remained unchanged (55.7% retrospectively and 50% prospec-
tively), in keeping with the 51.5% proportion in our cohort. Finally,
the proportion of type B3 fractures was  noticeably decreased in the
2005 study (24.8% retrospectively and 17.6% prospectively), sug-
gesting closer and more regular follow-up of patients with primary
THA. However, this possibility was  not borne out by our ﬁnding
that 20.5% of the fractures were type B3 in 2011. The tendency
to prefer conservative treatment for type C PPFs was conﬁrmed
in our study, as only 0.8% of these fractures were managed by
reTHA. The introduction of new locking ﬁxation devices has prob-
ably changed the management strategies for these distal fractures
[21].
Most reTHA procedures for PPF involved changing only the
femoral component, via the posterior approach, with a long and
usually unlocked stem, generally in combination with a cement-
less dual-mobility cup. The selection of these implant types was
designed to minimise the risk of dislocation while replicating the
native hip anatomy and femoral offset as closely as possible. In
the PPF group, similar proportions of patients had received long
locked stems and long unlocked stems. When the isthmus is intact,
a long, unlocked, cementless stem can be used, whereas a locked
stem is indicated when the isthmus is deﬁcient [22]. When the cup
had to be changed, a cementless dual-mobility cup was selected
to minimise the risk of dislocation, whose frequency after reTHA
is high, similar to that seen in primary THA for femoral neck
fracture [23]. For THA revision surgery, dual-mobility cups have
been proven effective [24–26]. Nevertheless, dislocation remained
the leading complication in our study, with a frequency of 4.7%
(11/234), which constitutes, however, a noticeable improvement
compared to the 10% and 15.6% frequencies in the retrospective
and prospective series reported in 2005 [10]. It is worth noting
that PPF management with internal ﬁxation was associated with
an extremely low dislocation rate (0% and 1.8% in the retrospective
and prospective series, respectively), emphasising the destabilising
effect of THA exchange, even when partial [10]. Nevertheless, the
use of a dual-mobility cup remains recommended in this indica-
tion.
Comparatively to the group without PPF, the group with PPF had
a larger proportion of patients managed by junior surgeons, a dif-
ference that probably contributes to explain the longer operative
time. However, the intra-operative complication rate was similar
in the PPF group and in the other group (5.9% versus 7.3%). Med-
ical complications (15.6%) were more common in the PPF group,
but the difference with the other group was not statistically sig-
niﬁcant. Similarly, the frequency of surgical complications was
similar after reTHA for PPF (12%) or other reasons (12.4%). Despite
the comparable medical and surgical morbidity rates, reTHA for
PPF remains a major procedure associated with non-negligible
mortality (4.8% within 3 months). The mortality rate is difﬁcult
to compare with those in the 2005 series [10], since the follow-
up durations were different (9.1% for the prospective series and
9.8% for the retrospective series). These mortality rates are fairlydistal femoral fractures [27,28]. The high morbidity and mortality
rates conﬁrm the need for multidisciplinary medical management
[25,29].
or peri-prosthetic fracture (PPF) across registries and published studies.
PPF (%) Rank among reasons for reTHA Leading reason for reTHA
4 Aseptic loosening
4 Aseptic loosening
5 Aseptic loosening
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4 Dislocation
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. Conclusion
In contrast with data from the main national registries, in our
tudy PPF was the second leading reason for reTHA. Compared to
atients with other reasons for reTHA, those with PPF were older,
ore vulnerable, and less physically active. Morbidity and mortal-
ty rates were high but consistent with those reported previously,
mphasising the major nature of the surgical procedure rather
han a role for the indication. Increased awareness among patients
nd surgeons about the need for regularly monitoring primary
HA is the only effective measure for preventing the development
f extensive damage, which increases the risk of a complex PPF
rocedure, technical difﬁculties during reconstruction, and higher
orbidity rates.
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